H-1B & Green Card Salary Data and Market Analysis
Total Filings
All time (charts below use selected years)Median Salary
Across filings in selected periodTop Employers
Hiring This RoleSee all H-1B/PERM filings for this role →
| Employer | Filings | Median Salary | Salary Range | Approval Rate |
|---|---|---|---|---|
| Mersana Therapeutics, Inc. | 6 | $109,205 | $100,000 - $121,275 | 83.3% |
| Gilead Sciences, Inc. | 5 | $141,898 | $129,355 - $162,000 | 100.0% |
| WAVE Life Sciences USA, Inc. | 3 | $94,160 | $88,000 - $102,000 | 100.0% |
| CASMA THERAPEUTICS, INC. | 1 | $100,000 | $100,000 - $100,000 | 100.0% |
| 23andMe, Inc. | 1 | $108,202 | $108,202 - $108,202 | 100.0% |
| Ensoma, Inc | 1 | $112,000 | $112,000 - $112,000 | 100.0% |
| Aligos Therapeutics | 1 | $100,000 | $100,000 - $100,000 | 100.0% |
| Atavistik Bio, Inc. | 1 | $105,331 | $105,331 - $105,331 | 100.0% |
| Experience Level | Filings | Median Salary | Salary Range |
|---|---|---|---|
| Senior | 18 | $108,306 | $88,000 - $162,000 |
| Principal | 1 | $121,275 | $121,275 - $121,275 |
| City | State | Filings | Median Salary |
|---|---|---|---|
| Cambridge | MA | 11 | $102,000 |
| Foster City | CA | 3 | $129,355 |
| South San Francisco | CA | 2 | $104,101 |
| Boston | MA | 1 | $112,000 |
These roles are variations of Senior Associate Scientist, Biology with different seniority levels.
| Role | Experience Level | Filings | Avg Salary |
|---|---|---|---|
| Senior Associate Scientist, Biology | 16 | $113,722 | |
| Senior Associate Scientist, Biology/Immuno-Oncology | 5 | $105,682 | |
| Principal Associate Scientist, Biology/Immuno-Oncology | 1 | $121,275 | |
| ASSOCIATE SCIENTISTS, BIOLOGY | Unspecified | 1 | $92,000 |
| Fiscal Year | Filings | Median Salary | Approval Rate |
|---|---|---|---|
| 2021 | 5 | $102,000 | 100.0% |
| 2022 | 3 | $100,000 | 66.7% |
| 2023 | 3 | $110,000 | 100.0% |
| 2024 | 5 | $108,410 | 100.0% |
| 2026 | 3 | $147,000 | 100.0% |
Compare how top companies pay for this role.
| Company | Filings | Median Salary | Approval Rate |
|---|---|---|---|
| Mersana Therapeutics, Inc. | 6 | $109,205 | 83.3% |
| Gilead Sciences, Inc. | 5 | $141,898 | 100.0% |
| WAVE Life Sciences USA, Inc. | 3 | $94,160 | 100.0% |
| CASMA THERAPEUTICS, INC. | 1 | $100,000 | 100.0% |
| 23andMe, Inc. | 1 | $108,202 | 100.0% |